Dr Natalie Kenny is the founder and CEO of BioGrad. A multi award winner in 2021, Dr Kenny is the current EVA’s Businesswoman of the Year, winner of The Business Desk Top 50 City Region Leader for Liverpool and winner of The Business Desk’s North West Investment Award among many other accolades. As well as 2021’s award triumphs, Dr Kenny has been awarded the 2022 Liverpool Women In Business, Woman of the year Award and is nominated for Awards at both the Northern Power Women Awards and the Northern Leadership Awards for 2022.

Dr Kenny has a rich background in scientific research with experience of working in ‘big pharmaceutical’ research for Pfizer as well as research roles for St George’s School of Medicine based in the Amazon Jungle, St John Hopkins Medical School based in Peru and the University of Extremadura in Spain. Her doctorate from Cranfield University is in the field of Translational Medicine with specialisation in ‘New Therapeutics For Rheumatoid Arthritis And Childhood Leukaemia.’ Throughout her already successful career, Dr Natalie Kenny has also had the chance to work on Neurological research in Cambridge as well as Allergy and Respiratory Diseases research in Kent. With a clear ambition to provide gold standard scientific, laboratory and clinical training to the next generation, Dr Kenny has the technical know-how, career, and life experience to really make a difference to the lives of the future’s scientists and clinicians